secwatch.observer — SEC 8-K summary
======================================

Issuer:     Camp4 Therapeutics Corp (CAMP)
CIK:        0001736730
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001628280-25-058009
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CAMP4 Therapeutics prices 5M share offering at $6.00, expects $28M net proceeds
-------------------------------------------------------------------------------

- CAMP4 Therapeutics priced public offering of 5,000,000 shares of common stock at $6.00 per share.
- Net proceeds expected to be approximately $28.0 million after underwriting discounts and expenses.
- Underwriting agreement with Leerink Partners LLC; closing expected on or about December 19, 2025.
- Executive officers, directors, and certain stockholders agreed to a 60-day lock-up on share sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/0001628280-25-058009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/camp-20251218.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-058009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer